Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 1 Hepatitis C Virus”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00612755
What this trial is testing

Efficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Genotype 1 and/or 4

Who this might be right for
HIV InfectionsHepatitis C
Hospital Clinico Universitario San Cecilio 43
Testing effectiveness (Phase 2)Study completedNCT00978497
What this trial is testing

Safety, Tolerability, and Antiviral Activity of ANA598 Administered in Combination With Pegylated Interferon and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection

Who this might be right for
HCV Infection
Hoffmann-La Roche 97
Testing effectiveness (Phase 2)UnknownNCT01727934
What this trial is testing

Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Santaris Pharma A/S 10
Large-scale testing (Phase 3)Study completedNCT02486406
What this trial is testing

Evaluate Treatment of Hepatitis C Virus Infection in Pediatric Subjects

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 64
Testing effectiveness (Phase 2)Ended earlyNCT02194998
What this trial is testing

Evaluating the Safety and Effectiveness of Interferon-Free Treatment of Hepatitis C Virus Infection in HIV-Coinfected Adults on Antiretroviral Therapy

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 46
Post-approval studies (Phase 4)Study completedNCT00077649
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C Infection (CHC).

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 188
Large-scale testing (Phase 3)Study completedNCT03235349
What this trial is testing

Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 160
Testing effectiveness (Phase 2)UnknownNCT01025297
What this trial is testing

Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in HCV Genotype 1 or 4 Patients Resistant to Bitherapy Alone

Who this might be right for
Hepatitis C
Cytheris SA 18
Post-approval studies (Phase 4)UnknownNCT02638233
What this trial is testing

Therapy With Ledipasvir/Sofosbuvir in Patients With Genotype 1 HCV Infection Receiving Opiate Substitution Therapy

Who this might be right for
Chronic Hepatitis C
Wilhelminenspital Vienna 40
Large-scale testing (Phase 3)Study completedNCT00411385
What this trial is testing

Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3

Who this might be right for
Chronic Hepatitis C
Human Genome Sciences Inc. 933
Testing effectiveness (Phase 2)Study completedNCT01516918
What this trial is testing

Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis

Who this might be right for
Chronic Hepatitis C Virus
Vertex Pharmaceuticals Incorporated 103
Testing effectiveness (Phase 2)Study completedNCT02349048
What this trial is testing

Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection

Who this might be right for
Hepatitis C Virus
Janssen Research & Development, LLC 68
Large-scale testing (Phase 3)UnknownNCT01441804
What this trial is testing

Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for Patients With Genotype 1 Hepatitis C and IL28B CC Polymorphism

Who this might be right for
Chronic Hepatitis C
Third Affiliated Hospital, Sun Yat-Sen University 200
Not applicableStudy completedNCT02798315
What this trial is testing

Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study

Who this might be right for
Chronic Hepatitis C
AbbVie 40
Large-scale testing (Phase 3)Study completedNCT00845065
What this trial is testing

Boceprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Participants With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05685AM2)(COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 202
Early research (Phase 1)Study completedNCT01202825
What this trial is testing

TMC647055HPC1001 - First-in-human Trial to Examine Safety, Tolerability and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses and of Increasing Repeated Oral Doses of TMC647055 in Healthy Volunteers and in Hepatitis C Virus Infected Patients

Who this might be right for
Hepatitis C
Tibotec Pharmaceuticals, Ireland 72
Large-scale testing (Phase 3)Study completedNCT01641640
What this trial is testing

Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 328
Testing effectiveness (Phase 2)Study completedNCT01455090
What this trial is testing

Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 320
Post-approval studies (Phase 4)Study completedNCT01033448
What this trial is testing

Extended Therapy of PEGASYS (Peginterferon Alfa-2a) in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C and Slow Response

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 59
Testing effectiveness (Phase 2)Study completedNCT01271790
What this trial is testing

Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 245
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation